7th World Conference

on Research Integrity

Cape Town, South Africa

29 May – 1 June 2022

30 May - 2 June 2021

Join the WCRI for a series of FREE Webinars taking place from 30 May to 2 June 2021.

Save the dates in your calendar – you don’t want to miss these informative and topical discussions!

Download the Programme.

WCRI 2021 Virtual

In light of the need to postpone the original face-to-face conference in Cape Town by one year to 2022, we’re pleased to host a virtual WCRI event on the original dates in 2021. 

From 30 May – 2 June 2021, we will host a series of webinars on six engaging and relevant topics as a precursor to our live event in 2022. These discussions will form part of the broader RI dialogue, and set a foundation we hope to build on in Cape Town when the RI community gather to – at long last – meet in person. 

Each topic will be broadcast live via webinar in two different time slots. This is to ensure that as many delegates as possible from around the world and in different time zones are able to participate.

The sessions are free of charge and will take place via Zoom.

Session Topics and Overviews

Each session will take place in the morning and be repeated in the evening to accommodate various time zone differences and increase accessibility to as many participants as possible. Please review the programme carefully as in some cases the morning and evening sessions may have different speakers, although the topic remains the same. 

Review the topic overviews below. Information may be subject to change.

Session 1 & 3 - What is Research Integrity?

This session is intended to provide a basic consideration of the fundamental principles and practices of research integrity.

Participants will be introduced to the field of research integrity, its purpose, a variety of practices and some key disciplinary resources. Consideration will be given to research misconduct and questionable research practices; why these are problematic; what impact they can have and how to avoid them. Participants will learn about “VIRT2UE Research Integrity training: An introduction to using the toolbox of resources.”

Participants should leave this session with an understanding of why fostering research integrity is beneficial to individual researchers, the research enterprise and institutions.

Session Co-Ordinator:
Paula Saner
Affiliation:  Research Integrity Coordinator, University of Cape Town

 

SESSION 1

Chair:
Prof Julia Priess-Buchheit
Affiliation:  Coburg University, Germany
Personal Page:  http://bit.ly/3q0E9se

Moderator:
Ms Limbanazo Matandika
Affiliation:  University of Cape Town, South Africa

Speakers:
Prof Edwin Were
Mr Daniel Pizzolato
Dr Natalie Evans

 

SESSION 3

Chair:
Dr Robert McLaughlin
Affiliation: Special Programs Advisor, Cancer Registry of Greater California, USA (former Senior Manager of UCT ORI)
Personal Page: http://bit.ly/2NyJwC1  

Moderator:
Prof Li Tang
Affiliation:  Fudan University, China
Personal Page: https://bit.ly/3bFvA11

Speakers:
Prof Theresa Rossouw
Adjuct Prof Michael Kalichman
Ms Giulia Inguaggiato

Session 2 & 4 - Carrot or stick? How might funders and publishers respond to new challenges for research integrity?
What can RFOs and journals do to foster research integrity?

The principles of research integrity remain, but the environment in which research is funded, performed, communicated and evaluated is constantly changing and evolving, creating many important questions.

For example, how is the technological revolution changing research integrity?

What happens when policy lags behind practice, between nations, regions, and globally?

What do new fields of research, like AI, mean for research integrity?

How do old incentives create new challenges for funders and for publishers?

Are there unintended consequences from new ways of assessing researchers and evaluating research?

These kinds of questions are important for funders and journal publishers to ask, and to begin to answer and answering questions like these successfully almost always means collaboration.

Speakers in each session, representing funders and representing publishers and journals, will – in turn – discuss emerging and new challenges. The session chair will then guide discussions about each, to identify shared concerns and potential actionable solutions, to deliver meaningful insights to a global audience.

 

Session Co-Ordinators:
Chris Graf
Affiliation:  Director, Research Integrity and Publishing Ethics, Wiley

Maura Hiney
Affiliation:  Head of Post-Award and Evaluation Health Research Board, Ireland

SESSION 2

Chair:
Dr Seeiso Koali
Affiliation: South African Medical Research Council (SAMRC)
Personal Page: http://bit.ly/2MwA3KS 

Moderator:
Dr Karen Salt
Affiliation:  UKRI
Personal Page: tbc

Speakers:
Suzanne Farley
IJsbrand Jan Aalbersberg

SESSION 4

Chair:
Alejandro Adem
Affiliation: NSERC
Personal Page: tbc

Moderator:
Ana Maria Fonseca
Affiliation: University of Campinas
Personal Page: tbc

Speakers:
Sioux Cumming
Tom Olyhoek
Carlos Henrique de Brito Cruz

Session 5 & 7 - Towards a Cape Town Statement on Fostering Research Integrity through equity, fairness and diversity.

The ‘Cape Town Statement’ is one proposed outcome of the 7th WCRI which will be discussed as a ‘Focus Track’ at 2022 conference. This session will introduce the thinking behind the proposal and, encourage as many people as possible to become involved in the development process.

There remain many challenges to achieving equity and fairness in research, particularly (but not exclusively) within the context of collaborations between the global North and South.

Issues of equity, fairness and diversity in research will be explored from the perspectives of a research institute Director, focusing primarily on unfairness in systems, and from the perspectives of an African researcher and scholar before engaging participants for a wider discussion.

The intended outcome of the focus track (post June 2022) will be a succinct statement of principles and action guides intended to support fairness and equity in research, research contexts and environments and research collaborations. A draft working paper may be distributed to attendees prior to this event.

 

Session Co-Ordinator:
Lyn Horn
Affiliation:  University of Cape Town, South Africa
Personal Page:  https://bit.ly/3bIrBR3 

SESSION 5

Chair:
Francis Kombe
Affiliation: ARIN
Personal Page: http://bit.ly/3aW7cZK 

Moderator:
Dr  Seeiso Koali
Affiliation:  RIO, South African Medical Research Council
Personal Page: http://bit.ly/2MwA3KS 

Speakers:
Prof Refiloe Masekela
Prof Allen Mukhwana

SESSION 7

Chair:
Francis Kombe
Affiliation: ARIN
Personal Page: http://bit.ly/3aW7cZK 

Moderator:
Dr  Seeiso Koali
Affiliation:  RIO, South African Medical Research Council
Personal Page: http://bit.ly/2MwA3KS 

Speakers:
Prof Ntobeko Ntusi
Prof Jim Lavery

 

Session 6 & 8 - Implementation of the Hong Kong Principles in Low and Medium Income Countries

Details coming soon

Session 9 & 11 - What can RPOs do to foster RI?

Research performing organizations (RPOs) like universities should help researchers to engage in responsible research practices and craft concrete policies and procedures for this purpose. To be consistent, coherent and effective RPOs need a Research Integrity Promotion Plan (RIPP).

The first presentation will explain how to design a RIPP, how to make it work, and where to find guidance and best practice examples.

The second presentation will discuss the practicalities and identify road blocks to avoid from the perspective of academic leaders devoted to fostering research integrity. Both speakers will subsequently engage with the participants in a panel discussion.

Session Co-Ordinator:
Lex Bouter
Affiliation:  Vrije Universiteit and Amsterdam University Medical Centers, The Netherlands
Personal Page:  https://research.vu.nl/en/persons/lex-bouter

Session Chair:
Lex Bouter
Affiliation:  Vrije Universiteit and Amsterdam University Medical Centers, The Netherlands
Personal Page:  https://research.vu.nl/en/persons/lex-bouter

Session Facilitator:
Krishma Labib
Affiliation: PhD student: Amsterdam University Medical Centers, Netherlands
Personal Page: https://research.vumc.nl/en/persons/krishma-labib

Session 10 & 12 - Research interpretation and data use with integrity in the COVID pandemic

 

The COVID pandemic has led to an unprecedented effort and speed of global research and data collection. While rapid dissemination of research findings and data can be a positive force for good, there are inherent dangers of data quality, misinterpretation, and outright fraud or falsification.

This session will explore two important areas where data and research integrity has been at particularly high stake during the COVID pandemic:

1) the speed of research and publication, including preliminary public posting of research and

2) presenting to and interpreting data for the public and policymakers transparently.

 

Session Co-Ordinator:
Sabine Kleinert
Affiliation: Senior Executive Editor, The Lancet

 

Session Chair:
Zoe Hammatt
Affiliation: University of Hawaii

Session Moderator:
Gowri Gopalakrishna
Affiliation:  Amsterdam UMC
Personal Page: https://research.vumc.nl/en/persons/gowri-gopalakrishna

Our Speakers

We have a panel of esteemed speakers lined up to share their thoughts and insights with participants. Read more about our speakers here.

Prof Edwin Were

Prof Edwin Were

Professor of Reproductive Health: Moi University Eldoret, Kenya

Dr. Were is a Professor in the Department of Reproductive Health, Moi University School of Medicine.

He is an experienced HIV Prevention researcher who has participated in groundbreaking clinical trials including Partners HIV Pre-Exposure Prophylaxis.

Additionally, Dr. Were has led the Institutional Research Ethics Committee for Moi University over the last 20 years, initially as Secretary, and now, as Chair.

He is a member of the Medicins san Frontiers, Ethics Review Board and is currently concluding an NIH supported project to build the Moi University
institutional capacity on Research Integrity. Dr. Were has over 50 peer-reviewed publications.

Dr Were will be Speaker One in Session 1 – What is Research Integrity? An educational introduction to the field of RI.

Mr Daniel Pizzolato

Mr Daniel Pizzolato

Doctoral candidate at the Centre for Biomedical Ethics and Law at KU Leuven

Daniel Pizzolato is a doctoral candidate at the Centre for Biomedical Ethics and Law at KU Leuven, where he researches the role of research integrity (RI) education and supervision in promoting scientific integrity under the supervision of Prof. Dierickx.

At KU Leuven, he is involved in the RI training of PhD students. Daniel is involved in two European funded projects on RI (SOPs4RI, VIRT2UE) and he is among the founders of the online platform “the Embassy of Good Science”.

Daniel has also investigated the ethical issues concerning the TOTAL trial on prenatal surgery.

Daniel holds a M.Sc. degree in Bioethics (KU Leuven-2018) and Chemistry and Pharmaceutical Technologies (University of Padua-2006).

Daniel will be Speaker Two in Session 1 – What is Research Integrity? An educational introduction to the field of RI.

 

 

Dr Natalie Evans

Dr Natalie Evans

Assistant Professor: Department of Medical Humanities of the VUmc

Dr. Natalie Evans is a Social Scientist with a long-term interest in ethics. She is an Assistant Professor at the Department of Medical Humanities of the VUmc.

Currently, Natalie is busy developing tools to support researchers in their day-to-day practices, and training to foster scientific virtues, as part of two large European Commission funded projects (EnTIRE and VIRT2UE).

She is the WP lead of the Stakeholder Consultation for EnTIRE, and the Scientific Manager for VIRT2UE. Natalie also gives Research Integrity Training for PhD students (Amstel Academy) and is an Associate Editor of the Journal Science and Engineering Ethics.

Dr Evans will be Speaker Three in Session 1 – What is Research Integrity? An educational introduction to the field of RI.

 

 

Prof Theresa Rossouw

Prof Theresa Rossouw

Professor of Immunology: University of Pretoria

Prof. Theresa Rossouw is a medical doctor and professor of Immunology at the University of Pretoria. She holds a double PhD – one in Philosophy and one in Medical Immunology.

Apart from being involved in HIV-related research, she also has a keen interest in ethics. She is the chairperson of the Research Ethics Committee (REC) of the HSRC and the deputy-chairperson of the REC of the Faculty of Health Sciences at the University of Pretoria.

She has been actively involved in research ethics and integrity training through SARETI, ARIN and ARESA.

Prof. Rossouw will be Speaker One in Session 3 – What is Research Integrity? An educational introduction to the field of RI.

  

Adjunct Prof Michael Kalichman

Adjunct Prof Michael Kalichman

Adjunct Professor of Pathology: UC San Diego, USA

Michael Kalichman, trained in engineering and neuropharmacology, has taught research ethics since 1990.

He is founding director of the UC San Diego Research Ethics Program (1997) and ethics service for the NIH CTSA-funded Clinical and Translational Research Institute (2010), and co-founding director for the Center for Ethics in Science and Technology (2004).

He has taught train-the-trainer, research ethics workshops throughout the U.S. and in Central and South America, Europe, Africa, Asia, and Australia, and has helped to create an Asia Pacific Research Integrity Network. He leads NIH- and NSF-funded research on the goals, content, and methods for teaching research ethics.

Daniel will be Speaker Two in Session 3 – What is Research Integrity? An educational introduction to the field of RI.

 

 

 

 

 

Ms Giulia Inguaggiato

Ms Giulia Inguaggiato

Scientific Co-ordinator: EnTIRE

Giulia Inguaggiato (MPhil), is a final year PhD candidate at the department of Ethics Law and Humanities of the Amsterdam University Medical Centres (NL).

She has a background in philosophy with a specific interest in ethics.

She is currently working on two large European Commission funded project on research integrity (EnTIRE and VIRT2UE) focussing on the creation of a community-based platform to support researchers in their day-to-day practices by providing them with tools, training materials, easily accessible information and peer support.

Giulia is the scientific coordinator of EnTIRE and one of the developers of the face-to-face components of train the trainer program developed by VIRT2UE. Giulia is also a teacher in the course for PhD students on Research Integrity (Amstel academy) and in the Master Course Philosophy Bioethics and Health offered at the VU Amsterdam.

Giulia will be Speaker Three in Session 3 – What is Research Integrity? An educational introduction to the field of RI.

  

 

Prof Refiloe Masekela

Prof Refiloe Masekela

Head of Department of Paediatrics and Child Health: University of KwaZulu Natal, South Africa

Professor Refiloe Masekela is a Pediatric Pulmonologist and current Head of Department of Paediatrics and Child Health at the University of KwaZulu Natal. She is also an Honorary Visiting Professor in the Centre for Genomics and Child Health at the Queen Mary University London, UK. 

She obtained her undergraduate medical degree at Witwatersrand University, and completed her specialist Paediatrics training at the University of Pretoria. She then completed her fellowship in Paediatric Pulmonology at the Catholic University in Leuven, Belgium and the University of Pretoria. She has experience in research over the past 14 years and is an NRF (C3) rated researcher having published over 60 publication in peer-reviewed journals and has co-authored 6 book chapters on paediatrics respiratory diseases. Professor Masekela is a nationally and internationally recognized expert in her field having held various leadership positions in local and international thoracic societies. Her research scientific career has focused on lung diseases in children. She has recently been appointed by the Minister of Health to the National Perinatal Mortality and Morbidity Committee.

She is the Vice-chairperson on the Pan African Thoracic Society (PATS), and the current Director of the American Thoracic Society (ATS) MECOR Africa program.  She is also a group member of the ATS Pediatric Global Health Group. Through PATS MECOR, she developed the African Women in Research Mentorship Program.

Professor Refiloe Masekela will be Speaker One in Session 5 – Towards a Cape Town Statement on Fostering Research Integrity through equity, fairness and diversity. 

Prof Allen Mukhwana

Prof Allen Mukhwana

Research Systems Manager at African Academy of Sciences, Kenya

Prof Allen M. Mukhwana joined African Academy of Sciences (AAS) as Research Systems Manager in November 2017. Allen is working with broad range of partners including researchers, funders, research management professionals and institutions to develop a programme for professionalising research and innovation management in Africa and provide leadership for the transformation of research systems and management.

Prior to joining AAS, Allen was Centre Manager for the Makerere University/Uganda Virus Research Institute Centre of Excellence for Infection and Immunity Research. Allen joined MUII-PLUS from the Infectious Diseases Institute, College of Health Sciences, Makerere University where she was the Senior Research Administrator and Head of Capacity Building for over six years. During this period, she established the research support functions and structures.

Allen is passionate about management of the research ecosystems in Africa, from governance and compliance, portfolio tracking, through to dissemination and reporting.

Professor Mukhwana will be Speaker Two in Session 5  – Towards a Cape Town Statement on Fostering Research Integrity through equity, fairness and diversity. 

Prof Ntobeko Ntusi

Prof Ntobeko Ntusi

Head of Medicine: Groote Schuur Hospital, South Africa

MBChB, FCP (SA), D.Phil, MD

Prof. Ntusi is the Head of Medicine and the Clinical Lead for cardiovascular magnetic resonance (CMR) and cardiovascular computed tomography (CCT) at Groote Schuur Hospital and is appointed as a Cardiologist, Professor and Chair of Medicine to the faculty in the Department of Medicine, University of Cape Town. His primary research interests comprise inflammatory heart disease (including HIV-associated cardiovascular disease), non-ischaemic cardiomyopathy and non-invasive imaging, with CMR. He has in-depth training and expertise in CMR and CCT.

 Prof. Ntusi has extensive experience with basic science, translational and clinical research. He currently supervises postgraduate students and is conducting several single-centre mechanistic clinical studies, which are mostly CMR-based. Through his research, Prof. Ntusi has built strong links with colleagues in clinical cardiology, physics and biomedical engineering, HIV medicine, rheumatology, immunology, molecular genetics and biomedical statistics; and he has shown capacity for performance in scientific investigational teams and is suited to being part of multi-disciplinary and multi-centre clinical studies. The current application builds logically on his work on CMR in HIV-associated heart disease.

Professor Ntusi will be Speaker One in Session 7  – Towards a Cape Town Statement on Fostering Research Integrity through equity, fairness and diversity. 

Niels Mejlgaard

Niels Mejlgaard

Professor of Political Science: Aarhus University, Denmark

Niels Mejlgaard is professor of Political Science and Associate Dean at the School of Business and Social Sciences at Aarhus University. Previously he served as director of the Danish Centre for Studies in Research and Research Policy.

He was trained in Political Science in Aarhus and did his doctoral work on the notion of ‘scientific citizenship’ at the Faculty of Engineering, Science and Medicine at Aalborg University.

He is interested in research policy and practice, and the interfaces between science, technology and society.

Currently he leads an international study concerned with the development of ‘Standard Operating Procedures for Research Integrity’ (SOPs4RI).

Niels will be Speaker One in Sessions 9 & 11 – What can RPOs do to foster RI? 

 

 

 

Rianne Letschert

Rianne Letschert

Rector Magnificus and Professor of Victimology and International Law: Maastricht University, the Netherlands

Professor Rianne Letschert (1976) studied Dutch Law and International Law at Tilburg University, the University of Amsterdam and the University of Montpellier and received her PhD in 2005. Her research focuses on the impact of international tribunals on societies and people who are confronted with serious violations of human rights and international crimes.

Since 1 September 2016, Professor Letschert is Rector Magnificus of Maastricht University. She is member of the Supervisory Board of Catharina Hospital Eindhoven and the Bonnefanten museum Maastricht. She is member of the Board of Trustees of Redress the Netherlands.

In 2019, she was awarded the title Topwoman of the year in the Netherlands.

Rianne will be Speaker Two in Sessions 9 & 11 – What can RPOs do to foster RI?

 

John McConnell

John McConnell

Editor-in-Chief, The Lancet Infectious Diseases

Dr. John McConnell is the Editor-in-Chief of The Lancet Infectious Diseases. He studied clinical microbiology and parasitology at the University of East London, before spending 6 years researching septic-shock-related topics at the Royal Postgraduate Medical School, Hammersmith Hospital, London (now part of Imperial College London).

He joined The Lancet in 1990, and was a peer-review editor before becoming the first editor of the journal’s website in 1996.

In 2001, John McConnell was the founding editor of The Lancet Infectious Diseases. He has been a member of the organising committee of numerous conferences, and has appeared as an expert commentator on BBC, ITV, Channel 4, Sky News, Al Jazeera, CNBC, CNN, and CCTV America.

John will be Speaker One in Session 10 – Research interpretation and data use with integrity in the COVID pandemic

 

John Nkengasong

John Nkengasong

Director of the Africa Centres for Disease Control and Prevention (Addis Ababa, Ethiopia)

Dr John Nkengasong currently serves as the first Director of the Africa Centres for Disease Control and Prevention (Africa CDC). He is a leading virologist with nearly 30 years of work experience in public health. Prior to his appointment with Africa CDC, he was the Deputy Principal Director (acting) of the Centre for Global Health at the United States Centres for Disease Control and Prevention, and Associate Director of Laboratory Science and Chief of the International Laboratory Branch at the Division of Global HIV/AIDS and TB.

Earlier in his career (1993 to 1995), Dr Nkengasong worked as Chief of Virology Laboratory at the Collaborating Centre on HIV Diagnostics at the Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium and later joined US CDC in 1994 as Chief of the Virology Laboratory in Abidjan, Cote d’Ivoire.

Earlier this year, the Director was appointed as one of the WHO Director-General’s Special Envoys on COVID-19 Preparedness and Response.

He received a Masters in Tropical Biomedical Science at the Institute of Tropical Medicine in Antwerp, Belgium, and a Doctorate in Medical Sciences (Virology) from the University of Brussels, Belgium.

Dr Nkengasong has received numerous awards for his work including Sheppard Award, the William Watson Medal of Excellence, the highest recognition awarded by CDC.

In September 2020, he was honored with the 2020 Goalkeepers Global Goalkeeper Award. He is also recipient of the Knight of Honour Medal by the Government of Cote d’Ivoire, was knighted in 2017 as the Officer of Loin by the President of Senegal, H.E. Macky Sall, and Knighted in November 2018 by the government of Cameroon for his significant contributions to public health.

He is an adjunct Professor at the Emory School of Public Health, Emory University, Atlanta, GA. He serves on several international advisory boards including the Coalition for Epidemic Preparedness Initiative – CEPI, the International AIDS Vaccine Initiative (IAVI) among others. He has authored over 250 peer-review articles in international journals and published several book chapters.

John will be Speaker Two in Session 10 – Research interpretation and data use with integrity in the COVID pandemic

 

Ivan Oransky

Ivan Oransky

Editor in Chief, Retraction Watch

Ivan Oransky is the Editor in Chief of Spectrum and a Distinguished Writer In Residence at New York University’s Carter Journalism Institute, where he teaches medical journalism in the Science, Health, and Environmental Reporting Program. He is also the president of the Association of Health Care Journalists. 

In the past, he’s been vice president of editorial at Medscape, vice president and global editorial director of MedPage Today, executive editor of Reuters Health, managing editor, online, of Scientific American, deputy editor of The Scientist, and editor-in-chief of the now-defunct Praxis Post. For three years, he taught in the health and medicine track at the City University of New York’s Graduate School of Journalism.

Ivan earned his bachelor’s at Harvard, where he was executive editor of The Harvard Crimson; and his MD at the New York University of School of Medicine. In 2015, he was awarded the John P. McGovern Award for excellence in biomedical communication from the American Medical Writers Association, and in 2017, received an honorary doctorate of civil laws from The University of the South (Sewanee).

Ivan will be Speaker One in Session 12 – Research interpretation and data use with integrity in the COVID pandemic

 

David Morens

David Morens

Senior Advisor to the Director of National Institute of Allergy and Infectious Diseases, National Institutes of Health.

 

David M. Morens serves as Senior Advisor to the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health. He received the A.B. degree (Psychology) in 1969 and the M.D. degree in 1973, both from the University of Michigan. 

He is Board Certified in Pediatrics (1978) and in Preventive Medicine (1980), with fellowship training in pediatric infectious diseases and additional training in virology. 

Dr. Morens served as a United States Public Health Service officer in CDC’s Epidemic Intelligence Service from 1976-1978; then served as a virologist in CDC’s Bureau of Laboratories, including two years studying Lassa fever in Sierra Leone, West Africa; and served as Chief of CDC’s Respiratory & Special Pathogens Branch, where he also represented the National Center for Infectious Diseases on CDC’s AIDS Task Force.

From 1982-1998 Dr. Morens served at the University of Hawai‘i, in the School of Medicine as Professor of Tropical Medicine, and as Professor and Chairman, Department of Family Practice & Community Health; in the School of Public Health as Professor and Chairman, Epidemiology Department; and in the College of Natural Sciences as Professor of Microbiology.  

In 1998 he joined the National Institute of Allergy and Infectious Diseases, where he remains on active duty in the United States Public Health Service.

Dr. Morens is past President of the American Epidemiological Society and current Chairman of the American Committee on Arthropod-Borne Viruses.  He has authored hundreds of scientific articles in major biomedical journals.  His career interest for over 45 years has been the study of emerging infectious diseases.  He speaks and writes frequently on numerous aspects of emerging diseases, on viral disease pathogenesis, and on the history of medicine and public health. 

David will be Speaker Two in Session 12 – Research interpretation and data use with integrity in the COVID pandemic

7th World Conference on Research Integrity © 2020. All rights reserved. | Privacy Policy

Conference Secretariat, Paragon Africa, Tel: +27 (0) 82 223 4684, Email: wcri2022@paragonafrica.co.za